Regulators

Global regulatory updates

Follow FDA, EMA, PMDA, MHRA, and other agencies across approvals, warnings, inspections, guidance, and drug policy signals.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

News

Pharma News

Daily pharmaceutical, biotech, medtech, and research coverage designed for search and discovery.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

81 stories in the current hub snapshot

🌍22h agoRegulatoryeof.gr

Featured signal

Δήλωση Αποθεμάτων Φαρμάκων Ανθρώπινης Χρήσης

Publisher

EOF Greece

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

EOF GreeceOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍1d agoRegulatoryeof.gr

ΑΝΑΚΟΙΝΩΣΗ ΣΧΕΤΙΚΑ ΜΕ ΔΙΟΡΘΩΤΙΚΟ 2025/90805 ΣΤΟΝ ΚΑΝΟΝΙΣΜΟ 1223/2009

EOF GreeceOriginal source

🇯🇵1d agoRegulatorypmda.go.jp

[IBENTO][IBENTO]The report for the PMDA Asia office GCP workshop 2026 has been posted.

PMDA JapanOriginal source

🇯🇵1d agoRegulatorypmda.go.jp

[IBENTO][IBENTO]The report for the PMDA Asia office GMP Workshop Training 2026 has been posted.

PMDA JapanOriginal source

🌍1d agoRegulatoryinfarma.pl

Julie Enevold Brooker oraz Gábor Sztaniszláv zostali wybrani do Zarządu Związku Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA

INFARMA PolandOriginal source

🇬🇧1d agoRegulatorygov.uk

Decision: Orphan registered medicinal products

MHRA UKOriginal source

🌍1d agoRegulatoryeof.gr

Κύρια σημεία συνεδρίασης της Επιτροπής Αξιολόγησης Κινδύνου Φαρμακοεπαγρύπνησης (PRAC), 8 – 11 Ιουνίου 2026

EOF GreeceOriginal source

🇧🇪1d agoRegulatoryfamhp.be

Tibsovo

FAMHP BelgiumOriginal source

🇬🇧1d agoRegulatorygov.uk

Guidance: Advice for consumers

MHRA UKOriginal source

🌍1d agoRegulatoryima.is

Minimum service from 20 July till 3 August

IMA IcelandOriginal source

🌍1d agoRegulatoryifpma.org

Pharmaceutical innovation key to delivering G7 leaders’ growth agenda

IFPMA GlobalOriginal source

🌍2d agoRegulatoryacrpnet.org

Patient Recruitment and Community Engagement Issues in the Spotlight from ACRP 2026

ACRP AssociationOriginal source

🌍2d agoRegulatorynafdac.gov.ng

2026 World Food Safety Day Capacity Building Event For NAFDAC Officers

NAFDAC NigeriaOriginal source

🌍2d agoRegulatorybioworld.com

Rx tariff just around the corner

BioWorld Regulatory RSSOriginal source

🌍2d agoRegulatoryeof.gr

Ανάκληση της παρτίδας H0444C του φαρμακευτικού προϊόντος NILOTINIB/TEVA caps 200mg/cap BT x 112

EOF GreeceOriginal source

🇬🇧2d agoRegulatorygov.uk

Guidance: COVID-19 test validation approved products

MHRA UKOriginal source

🌍2d agoRegulatoryifpma.org

Pharmaceutical industry mobilizes to support response to the Ebola Bundibugyo virus disease outbreak and calls for a system that enables rapid response and sustained R&D investment

IFPMA GlobalOriginal source

🌍3d agoRegulatoryacrpnet.org

Leveraging Artificial Intelligence for Clinical Trial Recruitment and Retention

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Reimagining the Clinical Research Coordinator in the Age of AI: A Commentary

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Bridging the Gap in Clinical Research: A Theory-Driven, Site-Centric Framework for AI Adoption and Literacy

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Implementation of AI for Future Clinical Data Review: A Literature Review

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

How AI and Regulatory Changes are Advancing Product Development

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Clinical Research in 2026: The Rise of Connected Development

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Clinical Trials Without the Traffic Jams: AI’s Role in Accelerating Discovery

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Self-Service Check-In, Serious Back-End: Untangling the Technology Behind Frictionless Clinical Trial Intake

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Building the Bridge: Why Embedding Clinical Research in the Patient Journey is the Defining Opportunity of This Moment

ACRP AssociationOriginal source

🌍3d agoRegulatoryacrpnet.org

Integrating Behavioral Health Support into Clinical Trial Participant Retention Strategies

ACRP AssociationOriginal source

🌍3d agoRegulatorybioworld.com

Oricell brings first pivotal-stage CAR T in liver cancer

BioWorld NMPA RSSOriginal source

🌍3d agoRegulatorybioworld.com

Chinese challenger Gan & Lee gains momentum in metabolic disease

BioWorld NMPA RSSOriginal source

🌍3d agoRegulatorybioworld.com

Three deals in six days: Everest builds late-stage APAC portfolio

BioWorld NMPA RSSOriginal source

🌍3d agoRegulatorybioworld.com

Longbio’s LP-003 meets phase III allergy endpoints

BioWorld NMPA RSSOriginal source

🌍3d agoRegulatorybioworld.com

China clears Alphamab’s HER2 bispecific antibody in gastric cancer

BioWorld NMPA RSSOriginal source

🇬🇧3d agoRegulatorygov.uk

ACE-inhibitors: Be aware of the distinction between bradykinin- and histamine-mediated angioedema, as treatment strategies differ significantly

MHRA UKOriginal source

🌍3d agoRegulatoryargentina.gob.ar

ANMAT prohíbe el tránsito interjurisdiccional de productos médicos de IGMA INSUMOS HOSPITALARIOS S.R.L.

ANMAT NoticiasOriginal source

🇬🇧3d agoRegulatorygov.uk

Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29

MHRA UKOriginal source

🌍3d agoRegulatoryifpma.org

High-Level Virtual Meeting of African Heads of States, Governments and Partners on Ebola Bundibugyo virus disease outbreak

IFPMA GlobalOriginal source

🇫🇷3d agoRegulatoryleem.org

INVITATION CONFERENCE DE PRESSE : Résultats 2026 du baromètre 360° de l’attractivité de la France pour l’industrie pharmaceutique

LEEM FranceOriginal source

🇯🇵4d agoRegulatorypmda.go.jp

[ANZEN]PMDA Risk Communications: Omeprazole etc. posted

PMDA JapanOriginal source

🇯🇵4d agoRegulatorypmda.go.jp

[ANZEN]Revisions of PRECAUTIONS: Lithium carbonate , etc. posted

PMDA JapanOriginal source

🌍4d agoRegulatorypharmac.govt.nz

Agenda for August 2026 Pharmacology and Therapeutics Advisory Committee (PTAC) meeting

Pharmac New ZealandOriginal source

🌍4d agoRegulatorybioworld.com

Proposed CMS rule aims to close fixed combo drug loophole

BioWorld Regulatory RSSOriginal source

🌍4d agoRegulatorybioworld.com

Longbio’s LP-003 meets phase III allergy endpoints

BioWorld NMPA RSSOriginal source

🌍4d agoRegulatorybioworld.com

Chinese challenger Gan & Lee gains momentum in metabolic disease

BioWorld NMPA RSSOriginal source

🇬🇧4d agoRegulatorygov.uk

Field Safety Notices: 8 -12 June 2026

MHRA UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Improved early warning systems needed to reduce medicines supply risks, says ABPI

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

The UK should seek to be a European leader for rare disease medicine, says new report

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

ABPI celebrates a month of major investment commitments into UK life sciences

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Medicine levy makes the UK un-investable, say pharma leaders

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Are NHS patients keeping up with European neighbours on access to new medicines?

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Time to emphasise the economics in health economics

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Latest Disclosure UK data: higher R&D spend, greater transparency and more partnership with the NHS

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

UK medicines investment: the case for improving the UK commercial environment

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Making Wales a destination for industry clinical trials and medical research

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

ABPI Regulatory Science symposium 2025

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Why the pharmaceutical industry needs NHS data to develop new medicines

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Disclosure UK 2024: new record for transparency, with nine in ten healthcare professionals named in database

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Speedy Anna is now award-winning

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Getting ready for the Windsor Framework: ensuring continuity of UK medicines supply beyond 1 January 2025

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Comparing new medicine availability across Europe

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

mRNA technology: navigating preclinical research for rare diseases

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

June’s story of sickle cell

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

Principles for analysis and use of health data by ABPI members

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

MHRA’s new International Recognition Procedure (IRP): how does it shape up?

ABPI UKOriginal source

🇬🇧4d agoRegulatoryabpi.org.uk

My sons have taught me more than I could ever teach them

ABPI UKOriginal source

🌍4d agoRegulatoryeof.gr

Απαγόρευση διακίνησης και διάθεσης του προϊόντος «LIGHT DIGEST Vanilla»

EOF GreeceOriginal source

🌍4d agoRegulatoryeof.gr

Ανάκληση παρτίδας του προϊόντος «ΤΟΛΥΠΙΑ XRAY DIAM 5CM 40X40» REF 24-0460

EOF GreeceOriginal source

🇧🇪4d agoRegulatoryfamhp.be

Bijdragen

FAMHP BelgiumOriginal source

🌍4d agoRegulatoryeof.gr

Eκτέλεση προϋπολογισμού ΕΟΦ μηνός Μαϊου 2026

EOF GreeceOriginal source

🌍Jun 13Regulatoryfifarma.org

América Latina llega a la mesa global de la salud: Yaneth Giha es elegida Vicepresidenta del Consejo de IFPMA

FIFARMA NewsOriginal source

🌍Jun 13Regulatorybioworld.com

Oricell brings first pivotal-stage CAR T in liver cancer

BioWorld NMPA RSSOriginal source

🇺🇸Jun 12Regulatoryciscrp.org

Customizing Clinical Trial Content for Boston Scientific’s Device Trials

CISCRP Patient InfoOriginal source

🇬🇧Jun 12Regulatorygov.uk

Decision: Medical devices given exceptional use authorisations

MHRA UKOriginal source

🌍Jun 12Regulatoryeof.gr

Εξάρθρωση κυκλώματος παράνομης παραγωγής και εμπορίας φαρμάκων

EOF GreeceOriginal source

🇯🇵Jun 12Regulatorypmda.go.jp

[YAKKYOKUKATA]PDG March 2026 News posted

PMDA JapanOriginal source

🌍Jun 12Regulatorybioworld.com

China clears Alphamab’s HER2 bispecific antibody in gastric cancer

BioWorld NMPA RSSOriginal source

🌍Jun 11Regulatoryinfarma.pl

Przedłużenie dodatkowego świadectwa ochronnego mogłoby dziesięciokrotnie zwiększyć inwestycje w badania i rozwój w Europie

INFARMA PolandOriginal source

🇬🇧Jun 11Regulatorygov.uk

Regulation of medical devices in Northern Ireland

MHRA UKOriginal source

🌍Jun 11Regulatoryeof.gr

Διακήρυξη υπ. Αριθ. 0/2/2026 Ηλεκτρονικού Ανοικτού κάτω των Ορίων Διαγωνισμού για την Προμήθεια μονάδων αποθήκευσης και υπηρεσιών μετάπτωσης

EOF GreeceOriginal source

🇬🇧Jun 11Regulatorygov.uk

Regulation of AI in Healthcare

MHRA UKOriginal source

🇬🇧Jun 11Regulatorygov.uk

Research: National Commission into the Regulation of AI in Healthcare: research, engagement and call for evidence findings

MHRA UKOriginal source

🇫🇷Jun 11Regulatoryleem.org

L'industrie pharmaceutique appelle le G7 à investir dans l'innovation pour stimuler la compétitivité, la résilience et la croissance

LEEM FranceOriginal source